LLMpediaThe first transparent, open encyclopedia generated by LLMs

Bacillus subtilis

Generated by Llama 3.3-70B
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Biology Letters Hop 3
Expansion Funnel Raw 92 → Dedup 24 → NER 8 → Enqueued 7
1. Extracted92
2. After dedup24 (None)
3. After NER8 (None)
Rejected: 16 (not NE: 16)
4. Enqueued7 (None)
Similarity rejected: 1
Bacillus subtilis
NameBacillus subtilis
DomainBacteria
PhylumFirmicutes
ClassBacilli
OrderBacillales
FamilyBacillaceae
GenusBacillus
SpeciesB. subtilis

Bacillus subtilis is a well-studied Gram-positive bacterium, closely related to Bacillus licheniformis and Bacillus pumilus, and is commonly found in soil and the gastrointestinal tract of animals, including humans. It is a model organism in the fields of molecular biology and genetics, and has been extensively studied by scientists such as Louis Pasteur and Robert Koch. The study of Bacillus subtilis has also been influenced by the work of Alexander Fleming and Selman Waksman, who discovered penicillin and streptomycin, respectively. Research on Bacillus subtilis has been conducted at institutions such as Harvard University and Stanford University.

Introduction

Bacillus subtilis is a rod-shaped bacterium that is approximately 2-3 μm in length and 0.7-0.8 μm in width, and is characterized by its ability to form endospores. It is a facultative aerobe, meaning that it can grow in the presence or absence of oxygen, and is commonly found in environmental samples, including water and air. The study of Bacillus subtilis has been influenced by the work of Louis Pasteur and Robert Koch, who developed the germ theory of disease and the gold standard for microbiological research, respectively. Researchers at MIT and University of California, Berkeley have also made significant contributions to the field of Bacillus subtilis research.

Taxonomy

Bacillus subtilis is a member of the Bacillaceae family, which includes other Gram-positive bacteria such as Bacillus anthracis and Bacillus thuringiensis. It is classified as a Firmicute, a group of bacteria that includes Clostridium difficile and Staphylococcus aureus. The taxonomy of Bacillus subtilis has been studied by scientists such as Carl Woese and George Fox, who developed the phylogenetic tree and the 16S ribosomal RNA sequencing method, respectively. Researchers at University of Oxford and University of Cambridge have also made significant contributions to the field of Bacillus subtilis taxonomy.

Physiology

Bacillus subtilis is a chemoheterotroph, meaning that it requires organic compounds for growth and energy. It is capable of growing on a wide range of carbon sources, including glucose, sucrose, and amino acids. The physiology of Bacillus subtilis has been studied by scientists such as Hans Krebs and Fritz Lipmann, who discovered the citric acid cycle and the coenzyme A, respectively. Researchers at University of Chicago and Columbia University have also made significant contributions to the field of Bacillus subtilis physiology.

Genetics

The genome of Bacillus subtilis consists of a single circular chromosome that is approximately 4.2 million base pairs in length. It contains approximately 4,100 genes, including genes involved in DNA replication, transcription, and translation. The genetics of Bacillus subtilis has been studied by scientists such as James Watson and Francis Crick, who discovered the structure of DNA and developed the central dogma of molecular biology, respectively. Researchers at California Institute of Technology and University of Wisconsin-Madison have also made significant contributions to the field of Bacillus subtilis genetics.

Applications

Bacillus subtilis has a number of practical applications, including the production of enzymes, antibiotics, and vaccines. It is also used as a probiotic and has been shown to have health benefits in animals and humans. The use of Bacillus subtilis in biotechnology has been influenced by the work of Herbert Boyer and Stanley Cohen, who developed the recombinant DNA technology and the plasmid cloning method, respectively. Researchers at University of Illinois at Urbana-Champaign and Purdue University have also made significant contributions to the field of Bacillus subtilis applications.

Pathogenesis

Although Bacillus subtilis is generally considered to be a non-pathogenic bacterium, it can cause disease in animals and humans under certain circumstances. For example, it can cause infections in immunocompromised individuals and has been implicated in the development of food poisoning. The pathogenesis of Bacillus subtilis has been studied by scientists such as Robert Gallo and Luc Montagnier, who discovered the HIV virus and developed the ELISA test, respectively. Researchers at Johns Hopkins University and University of Pennsylvania have also made significant contributions to the field of Bacillus subtilis pathogenesis. Category:Bacteria